Altoona center for clinical research

Duncansville, Pennsylvania 16635-8406

17 studies enrolling now · 327 studies all time

What they study most

Active Psoriatic Arthritis, Acute Gout, Adhesive Capsulitis, Age Related Osteoporosis, Allergic Rhinitis, Analgesia, Ankylosing Spondylitis, Ankylosing Spondyloarthritis, Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Atherosclerotic Cardiovascular Disease

Studies at this site

A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee — Recruiting now
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout — Recruiting now
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Recruiting now
A Study of Dotinurad Versus Allopurinol in Participants With Gout — Recruiting now
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) — Recruiting now
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) — Recruiting now
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia — Recruiting now
RA-PRO PRAGMATIC TRIAL — Recruiting now
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain — Recruiting now
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain — Recruiting now
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE) — Recruiting now
Study of GS-0151 in Participants With Rheumatoid Arthritis — Recruiting now
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine — Recruiting now
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis — Recruiting now
A Study of RSLV-132 in Females With Sjögren's Disease — Recruiting now
Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis — Running, not enrolling
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus — Completed
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain — Running, not enrolling
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain — Starting soon
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis — Completed
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD — Running, not enrolling
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation — Running, not enrolling
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain — Starting soon
A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza — Running, not enrolling
A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis — Stopped early
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis — Stopped early
Study of GS-0272 in Participants With Rheumatoid Arthritis — Stopped early
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) — Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight — Completed
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) — Running, not enrolling
Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee — Completed
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity — Running, not enrolling
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) — Running, not enrolling
Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia — Completed
A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II — Completed
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers — Completed
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) — Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — Completed